Lindbrook Capital, LLC
- SEC CIK
- 0001767045
- Latest filing
- May 5, 2025
DSGN holding history
Design Therapeutics, Inc. in every 13F filed by Lindbrook Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DSGN overviewAll 13F holders of DSGNFull Q1 2025 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −607−100.0% | Sold out | Holders |
| Q2 2023 | 607 | $3.82K | <0.1% | −928−60.5% | Reduced | Holders |
| Q1 2023 | 1,535 | $8.86K | <0.1% | +1,535 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −78−100.0% | Sold out | Holders |
| Q3 2022 | 78 | $1.00K | <0.1% | +78 | New | Holders |